Medical Device CE Marking Strategy
Healthcare
Market Research
Regulatory Strategy
Partnership Facilitation
Berlin
2023
Korean medical device startup with innovative diagnostic platform required European regulatory pathway analysis and partnership strategy for CE marking and market entry.
Summary
Medical technology startup with 25 employees developed diagnostic platform requiring European market entry strategy. Technology offered clinical advantages but faced CE marking requirements and distribution partnership needs. Client with limited runway needed efficient regulatory pathway and commercial partnership enabling European launch within 12-18 months.
Assignment scope included EU Medical Device Regulation compliance strategy, CE marking pathway analysis, distributor identification, and commercial partnership facilitation balancing regulatory requirements with resource constraints.
Challenge
European medical device regulatory environment required CE marking with notified body approval creating timeline and cost uncertainty. Startup resources limited ability to navigate complex regulatory process independently. Client needed cost-effective pathway to CE marking without expensive regulatory consultants.
Distribution partnership required demonstrating technology advantages while protecting intellectual property with limited negotiation leverage. European distributors preferred established products with proven market acceptance. Client needed strategy attracting distributor interest despite startup status.
Regulatory classification uncertainty impacted CE marking pathway complexity. Client needed clear understanding of applicable requirements and realistic timeline estimates. Limited clinical data required strategic approach to evidence generation within budget constraints.
Solutions
SYL developed pragmatic regulatory and commercial strategy. Luxembourg research team analyzed MDR requirements and identified Class IIa classification pathway with manageable technical documentation requirements. Regulatory roadmap outlined notified body selection strategy and estimated 10-12 month CE marking timeline.
Commercial analysis identified specialized diagnostic distributors serving specific medical specialties where client's technology offered clear advantages. SYL facilitated introductions with three German medical device distributors focusing on point-of-care diagnostics. Partnership discussions emphasized technology differentiation and market opportunity rather than extensive track record.
Partnership strategy succeeded with German distributor agreement providing European market access. Distributor contributed regulatory support and clinical site access for validation studies in exchange for exclusive distribution rights in DACH region. Agreement preserved client's technology ownership while enabling resource-efficient European entry.
Results demonstrated successful SME market entry strategy. Client achieved CE marking within 12 months with €180K total regulatory investment. Distributor partnership enabled market launch without independent sales infrastructure investment. Initial European sales reached €420K in first year with expansion to additional markets planned.
